BUY Tatva Chintan Pharma Chem Limited — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)20 Oct 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Tatva Chintan Q2 Review: ICICI Securities Hikes Target Price After Strong Numbers; Check Potential Upside
NewsNdtv-Profit·21 Oct · today
Tatva Chintan shares hit another 52-week high after reporting highest-ever quarterly turnover
NewsCnbc-Tv18·21 Oct · today
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·21 Oct · today
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Tatva Chintan Pharma Chem
- BUY — Aastha Jain, Hem Securities21 Oct 2026 · ~2 weeks · target ₹1,995 · Expired
- BUY — Ansh Jogendra Bhilwar21 Oct 2026 · ~2 weeks · target ₹2,000 · Expired
- BUY — Kush Bohra24 Sept 2026 · ~2 weeks · target ₹1,915 · SL hit
- BUY — Vaishali Parekh, Prabhudas Lilladher27 Aug 2026 · ~2 weeks · target ₹1,850 · Expired
- BUY — Laxmikant Shukla, YES Securities20 Jul 2026 · ~2 weeks · target ₹1,820 · Target hit
More from ICICI Securities
- BUY Just Dial21 Oct 2026 · ~1 year · target ₹850 · Active
- BUY Union Bank of India20 Oct 2026 · ~1 year · target ₹230 · Active
- BUY Rossari Biotech20 Oct 2026 · ~1 year · target ₹520 · Active
- BUY Crompton Greaves Consumer Electricals19 Oct 2026 · ~1 year · target ₹275 · Active
- BUY L&T Finance19 Oct 2026 · ~1 year · target ₹325 · Active

